agonistas del receptor glp 1 Fármacos basados en GLP-1: mecanismos implicados en el tratamiento de la obesidad Agonistas duales de receptores GLP-1

These findings suggest that while GLP-1 medications produce generalized fat loss throughout the body, abdominal fat deposits appear to respond as part of this overall weight reduction, likely due to the metabolically active nature of visceral adipose tissue

Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis

doi:10.2478/rjim-2018-0035

Both semaglutide and tirzepatide are designed to be used long-term, meaning patients may regain weight if the treatment is stopped

Tripeptide Wound Healing & ECM Remodelling Review (Med Sci, 2025) A comprehensive 2025 review of tripeptides in wound healing and skin regeneration confirmed GHK-Cu as the most studied tripeptide in the context of wound repair and scar minimisation

J Biol Chem (2006) 281:115968